Mark Oldham

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 85(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12226483 - Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use (2025-02-18),

2. 11992697 - X-ray psoralen activated cancer therapy (X-PACT) (2024-05-28),

3. 11865359 - Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties (2024-01-09),

4. 11786595 - Methods for radiotherapy to trigger light activation drugs (2023-10-17),

5. 11577092 - Phosphor-containing drug activator activatable by a monte carlo derived X-ray exposure, system containing the activator, and methods for use (2023-02-14),

6. 11305131 - X-ray psoralen activated cancer therapy (X-PACT) (2022-04-19),

7. 11260129 - Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use (2022-03-01),

8. 11207409 - X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments (2021-12-28),

9. 11135294 - Methods for radiotherapy to trigger light activation drugs (2021-10-05),

10. 10940329 - Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use (2021-03-09),

11. 10670874 - Light-collimating tank for use with an optical computed tomography system (2020-06-02),

12. 10617892 - Methods for generating accurate radiation dose maps corrected for temporal and spatial changes arising in remote dosimetry applications (2020-04-14),

13. 10596387 - Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties (2020-03-24),

14. 10441810 - X-ray psoralen activated cancer therapy (X-PACT) (2019-10-15),

15. 7532705 - Systems and methods for localizing a target for radiotherapy based on digital tomosynthesis (2009-05-12),

Sure, I will create an article based on the information provided. Here is the structured article:

Title: Mark Oldham: Innovator in Tumor Imaging and Radiotherapy

Introduction:

Mark Oldham, a prolific inventor based in Durham, North Carolina (US), has made significant contributions to the field of medical imaging and radiotherapy. With a total of 13 patents to his name, Oldham’s innovative work focuses on utilizing photon-emitting phosphors for imaging and treating diseases in the human or animal body.

Latest Patents:

Oldham’s latest patents showcase his groundbreaking ideas in the field of medical technology. One of his patents involves a system and method for tumor imaging with x-rays and high-energy sources using photon-emitting phosphors with therapeutic properties. This invention aims to provide precise imaging and treatment of diseases within the body, utilizing advanced technologies.

Another notable patent by Mark Oldham is a method for radiotherapy to trigger light activation drugs. This method offers a novel approach to treating disorders by activating photoactivatable drugs within the subject using Cherenkov radiation (CR) light.

Career Highlights:

Mark Oldham has an impressive career history, having worked with esteemed institutions and companies. He has been associated with Duke University, a renowned research institution known for its pioneering work in various fields. Additionally, Oldham has contributed his expertise to Immunolight, LLC, a company focused on innovative medical solutions.

Collaborations:

Throughout his career, Mark Oldham has collaborated with talented individuals in the field of medical technology. Notable coworkers include Harold Walder and Zakaryae Fathi, who have worked alongside Oldham in developing cutting-edge solutions for tumor imaging and radiotherapy.

Conclusion:

In conclusion, Mark Oldham stands out as a visionary inventor in the realm of medical technology, with a strong focus on advancing tumor imaging and radiotherapy techniques. His patents reflect his dedication to improving healthcare outcomes through innovative approaches. With a track record of successful collaborations and a wealth of expertise, Mark Oldham continues to shape the future of medical innovation with his groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.